Joint life care annuities to help retired couples to finance the cost of long-term care

Ventura-Marco, Manuel; Vidal-Meliá, Carlos; Pérez-Salamero González, Juan Manuel

doi:10.1016/j.insmatheco.2023.08.002

Cited by 2 publications

(1 citation statement)

References 82 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…From the point of view of potential purchasers of this type of insurance product, the disclosure of the summary health/longevity measures used in the technical bases to compute LTCI and LCA premiums would help them to understand the need to be protected against the cost of requiring LTC services and also make the computation of the actuarial factors transparent (Ventura-Marco et al 2023). This information could also be embedded in the retirement calculators and other tools used by financial advisors, given that many people are simply unaware of longevity (and morbidity) risks (Hurwitz et al 2022).…”

Section: Conclusion and Future Researchmentioning

confidence: 99%

Analyzing the demographic coherence of selected US, Australian and Chinese biometric data sets used to price long-term care insurance and life care annuities

Vidal-Meliá,

Ventura-Marco,

Garvey

2023

Qual Quant

Self Cite

View full text Add to dashboard Cite

This paper examines the implicit healthy life expectancy used for actuarial calculations in some selected biometric data sets from the US, Australia and China. We are interested in checking the demographic/epidemiological coherence of these data sets because this health indicator is rarely presented when authors build their biometric data sets, nor when they are used to calculate long-term care insurance (LTCI) and life care annuity (LCAs) premiums, nor when they are employed in research articles to estimate the future demand for LTC services. We follow a methodology based on multistate life table methods that enables us to obtain a life expectancy matrix for individuals on the basis of their initial health state. We also present some additional indicators of longevity, mortality and morbidity, these being the median age at death, the interquartile range, the weighted modal age at death, the mortality ratio and the implicit LTC prevalence rates broken down by health state. We find several weaknesses that highlight the difficulty involved in building the biometric data sets needed to make an actuarially fair valuation of the premiums for LTCI and LCAs. We also verify the existence of the so-called “male–female health-survival paradox”. From the perspective of a potential purchaser of this type of insurance products, disclosing and explaining the summary measures of health and longevity would make it easier for them to understand the need to protect themselves against the cost of possible LTC services and also make the computation of the premiums more transparent.

show abstract

Section: Conclusion and Future Researchmentioning

confidence: 99%